Fauci Unfazed as Scientists Rely on Unproven Methods to Create COVID Vaccines
Teams are starting to test vaccines using messenger RNA or chimpanzee cold viruses to inoculate humans. Will their benefits last?
Vaccines
741 - 760 of 818 Results
-
-
KHN鈥檚 鈥榃hat The Health?鈥: Republicans in COVID Disarray
President Donald Trump鈥檚 sobering view of COVID-19 didn鈥檛 last long 鈥 this week, he was back to pushing hydroxychloroquine, a drug that has been shown not to work in treating the virus. Meanwhile, Republicans on Capitol Hill are still scrambling to agree among themselves and with the White House on the next coronavirus relief bill, as both a moratorium on evictions and extra unemployment payments expire. And the debate over drug prices, which was going to be one of the biggest health issues of this election year, makes a brief appearance. Alice Miranda Ollstein of Politico, Mary Ellen McIntire of CQ Roll Call and Anna Edney of Bloomberg News join KHN鈥檚 Julie Rovner to discuss this and more. Also, Rovner interviews KHN鈥檚 Markian Hawryluk, who wrote the latest KHN-NPR 鈥淏ill of the Month鈥 story about a surprise bill from a surprise surgical assistant.
-
Public Health Experts Fear a Hasty FDA Signoff on Vaccine
The FDA must approve any coronavirus vaccine before it鈥檚 widely distributed, but political pressure could cloud the decision.
By Arthur Allen -
A Coronavirus Vaccine: Where Does It Stand?
Under ordinary circumstances, these phases of vaccine development can take years to complete. But now, during the age of coronavirus, the timeline is being shortened. Here's an inventory of where things stand.
-
Shingles Vaccination Rate Soars But Leaves Many Behind
A federal study finds 35% of people 60 and older were vaccinated for shingles by 2018, up from 7% in 2008, but low-income people and those who are Black or Hispanic are far less likely to get vaccinated.
-
Analysis: How A COVID-19 Vaccine Could Cost Americans Dearly
The United States is the only developed nation unable to balance cost, efficacy and social good in setting prices.
-
Must-Reads Of The Week
Easy-breezy guest writer Rachel Bluth fills you in on a healthy dose of news from this past week.
By Rachel Bluth -
KHN鈥檚 鈥榃hat the Health?鈥: SCOTUS, Trump Collide Over Transgender Rights
The Trump administration rolled back protections for transgender patients just days before the Supreme Court cemented LGBTQ rights under the Civil Rights Act. So, what now? Meanwhile, coronavirus politics reaches beyond health care settings. Anna Edney of Bloomberg News, Tami Luhby of CNN and Shefali Luthra of KHN join KHN鈥檚 Julie Rovner to discuss this and more. Also, for extra credit, the panelists recommend their favorite health stories of the week they think you should read, too.
-
Must-Reads Of The Week
KHN senior correspondent Jordan Rau spins through this week鈥檚 essential health care news.
By Jordan Rau -
Must-Reads Of The Week
KHN executive editor Damon Darlin wades through mounds of health care policy stories 鈥 so you don鈥檛 have to.
By Damon Darlin -
KHN鈥檚 鈥榃hat The Health?鈥: When It Comes To COVID-19, States Are On Their Own
Just about every state is lifting some coronavirus-related restrictions, but it鈥檚 unclear how things are really going, considering data on the spread of the virus lags and may not be reliable. Meanwhile, the federal government continues to throw more responsibility for dealing with the pandemic to state and local governments. Margot Sanger-Katz of The New York Times, Kimberly Leonard of Business Insider and Alice Miranda Ollstein of Politico join KHN鈥檚 Julie Rovner to discuss this and more.
-
Analysis: Get Ready For The Vaccine 鈥 They鈥檙e Never Simple
Trials are an immense undertaking involving tens of thousands of participants. They鈥檙e likely to start this summer 鈥 but don鈥檛 expect quick results. And what鈥檚 a successful result, anyway?
By Arthur Allen -
Drugmakers Tout COVID-19 Vaccines To Refurbish Their Public Image
Vaccines and antivirals have long been an afterthought but Johnson & Johnson and other firms are widely publicizing how they might stop COVID 19.
By Jay Hancock -
Must-Reads Of The Week From Brianna Labuskes
Newsletter editor Brianna Labuskes wades through hundreds of health care policy stories each week, so you don鈥檛 have to.
-
Chasing The Elusive Dream Of A COVID Cure
Thousands of researchers worldwide are looking for a treatment that will go beyond what remdesivir can do for COVID patients.
By Liz Szabo -
Must-Reads Of The Week From Brianna Labuskes
Newsletter editor Brianna Labuskes wades through hundreds of health care policy stories each week, so you don't have to.
-
Postcard from Kalispell, Montana
How The Pandemic And An Anti-Vax Health Official Are Roiling A Montana Community
In one conservative pocket of Montana, a local health board member who opposes vaccinations helped fight the state鈥檚 stay-at-home rules. But now, as the state slowly reopens, she faces a backlash of her own.
-
Must-Reads Of The Week From Brianna Labuskes
Newsletter editor Brianna Labuskes wades through hundreds of health care policy stories each week, so you don't have to.
-
Anti-Vaccine Activists Latch Onto Coronavirus To Bolster Their Movement
Activists failed to convince state legislators that diseases like measles aren鈥檛 serious enough to require vaccination. Now they鈥檙e joining with conservatives and other anti-lockdown demonstrators who contend the coronavirus isn鈥檛 dangerous enough to justify staying home.
By Liz Szabo -
Must-Reads Of The Week From Brianna Labuskes
Newsletter editor Brianna Labuskes wades through hundreds of health care policy stories each week, so you don't have to.